SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1426MGI PHARMA & HELSINN SUBMIT NDA FOR PALONOSETRON harrisdirect.comDavid Cathcart-9/27/2002
1425MGI PHARMA & HELSINN Announce Presentation of Positive Palonosetron Phase 3 David Cathcart-6/25/2002
1424From the MGI Pharma annual meeting last week... Lonnie Moulder, the new presideDavid Cathcart-5/21/2002
1423>>ORLANDO, Fla.--(BUSINESS WIRE)--May 20, 2002-- MGI PHARMA, Inc., (Nasdaqtuck-5/20/2002
1422>>ORLANDO, Fla.--(BUSINESS WIRE)--May 18, 2002--MGI PHARMA, Inc., (Nasdaq:tuck-5/18/2002
1421>>MINNEAPOLIS, May 7 (Reuters) - MGI Pharma Inc. (NasdaqNM:MOGN - news) ontuck-5/7/2002
1420Interesting post on Yahoo MOGN board this morning: From Dr. Garren's newsleDavid Cathcart-4/30/2002
1419Duquesne Capital Has 6% Stake In MGI Pharma DOW JONES NEWSWIRES WASHINGTON -- DJim Oravetz-4/24/2002
1418But the fall was clearly overdone here - I more than doubled up my small positioBiomaven-4/17/2002
1417>>MINNEAPOLIS--(BUSINESS WIRE)--April 17, 2002--MGI PHARMA, INC., (Nasdaq:tuck-4/17/2002
1416another sad day 04/17 7:23A (DJ) PRESS RELEASE: MGI Stops Phase 3 Pancreatic CVector1-4/17/2002
1415<i>When they are confronted with new style drugs and technology where theyBiomaven-4/12/2002
1414IMO, this post from last night on Yahoo is worth repeating here for those intereDavid Cathcart-4/12/2002
1413Should say IMO, Iro has synergy with these other drugs. They will not do a comboseminole-4/10/2002
1412MGI Pharma Says Study Shows Irofulven Effective DOW JONES NEWSWIRES MINNEAPOLISJim Oravetz-4/10/2002
1411Going to archive this since Yahoo! links expire . . . >>MINNEAPOLIS-tuck-2/13/2002
1410Quite detailed in guidance for 2002. biz.yahoo.comtom pope-2/13/2002
1409>>MINNEAPOLIS & MONTREAL, Jan 29, 2002 (BUSINESS WIRE) -- MGI PHARMA, tuck-1/31/2002
1408mgipharma.com Click on Corporate Presentations - 1/16/2002 Update 35 pages, somJim Oravetz-1/21/2002
1407>>MINNEAPOLIS & LUGANO, Switzerland--(BUSINESS WIRE)--Jan. 16, 2002--Mtuck-1/16/2002
1406>>MINNEAPOLIS--(BUSINESS WIRE)--Dec. 13, 2001--MGI PHARMA, INC., (Nasdaq:Mtuck-12/13/2001
1405I don't trade MOGN but.... After a stock sale the price drifts up a point oseminole-11/27/2001
1404I could see them inlicensing something and starting more trials on it, yup. Lootuck-11/27/2001
1403Why now? Me thinks they would be better off selling shares early next year. Me seminole-11/27/2001
1402>>MINNEAPOLIS--(BUSINESS WIRE)--Nov. 27, 2001--MGI PHARMA, INC., (Nasdaq:Mtuck-11/27/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News